טוען...

The p53 Upregulated Modulator of Apoptosis (PUMA) Chemosensitizes Intrinsically Resistant Ovarian Cancer Cells to Cisplatin by Lowering the Threshold Set by Bcl-x(L) and Mcl-1

Ovarian cancer is the number one cause of death from gynecologic malignancy. A defective p53 pathway is a hallmark of ovarian carcinoma. The p53 mutation correlates significantly with resistance to platinum-based chemotherapy, early relapse and shortened overall survival in ovarian cancer patients....

תיאור מלא

שמור ב:

מידע ביבליוגרפי
Main Authors:	Yuan, Zhu, Cao, Kang, Lin, Chao, Li, Lei, Liu, Huan-yi, Zhao, Xin-yu, Liu, Lei, Deng, Hong-xin, Li, Jiong, Nie, Chun-lai, Wei, Yu-quan
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	ScholarOne 2011
נושאים:	Articles
גישה מקוונת:	https://ncbi.nlm.nih.gov/pmc/articles/PMC3321807/ https://ncbi.nlm.nih.gov/pubmed/21863213 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2011.00176
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

The p53 Upregulated Modulator of Apoptosis (PUMA) Chemosensitizes Intrinsically Resistant Ovarian Cancer Cells to Cisplatin by Lowering the Threshold Set by Bcl-x(L) and Mcl-1

פריטים דומים